Azurin-p28

DB17241Investigational

Azurin-p28: Overview.

Mechanism: Pharmacologically active on Vascular endothelial growth factor receptor 2, Cellular tumor antigen p53, and Tumor protein p73
Curator reviewed
Code names: NSC-745104 · P28

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Azurin-p28, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.